Ten Brief Articles on ‘Biobanks & Industry’

Either select the title link to view on LinkedIn, or select download pdf

1. Why Biobanks Should Provide Biosamples to Industry

First and foremost, the main reason why biobanks should provide biosamples to industry is that industry plays a vital role in bringing new and improved drug and diagnostic products to the patient, but industry can only achieve this if  … Download pdf

2. Ensuring Public Support for Biobank Cooperation With Industry

This article starts by considering what past studies have shown about public attitudes to biobank cooperation with industry. The lack of public awareness about biobanking itself is highlighted and the article concludes by  … Download pdf

3. The Main Actors Providing Biosamples to Industry

Here we look at the main actors providing human biosamples to industry (pharma, diagnostic and biotech companies), and give special attention to the different approaches in the USA and Europe. The role of commercial biobanks will be. … Download pdf

4. Biosample Needs of Different Industry Players

This article examines three different actors in industry that require biosamples including: Large pharmaceutical companies; Large in vitro diagnostics companies; Small and medium enterprises (SMEs) in healthcare biotechnology. The article describes the major differences that exist between these different actors … Download pdf

5. The Dual Role of Academic Biobanks

Academic biobanks have a dual role: they need to support two actors in a production that leads to new drugs and diagnostics with resulting advances in patient care. The two actors they need to support are (1) researchers in academia and (2) researchers in industry. It is only by the efforts of both. … Download pdf

6. What is Commodification?

What is commodification? According to one dictionary definition it is ‘the action or process of treating something as a mere commodity’. A commodity is ‘a substance or product that can be traded, bought, or sold’. Commodification is a word generally used in a disapproving sense, especially if we talk about  … Download pdf

7. Acceptable Transactions in Biobanking

In this article we consider what financial transactions in biobanking are legally acceptable, focussing particularly on the Council of Europe’s Oviedo Convention …  Download pdf

8. Why Biobank Access Policies Should Be Publicly Available

The process of finding a suitable academic biobank is not easy for industry researchers. Not only must the biobank have the biosamples required, but also it must have policies that allow industry access. Biobank access policies may contain exclusion criteria that prevent industry access, or conditions of access that  … Download pdf

9. Why Researchers Must Know About Biosample Provenance

Every biosample used for medical research has a different journey. The journey starts when the sample is donated by a person. The journey ends when the sample is analysed in a research laboratory. In between, there are a wide variety of possible routes, events and timelines, all of which may have the potential to … Download pdf

10. Biosample Supply Problems Affecting Industry Research And Tomorrow’s Patients

This article looks at the various biosample supply problems affecting industry and explains the need for commercial biobanks. It looks at ways to overcome biosample supply problems in the interests of tomorrow’s patients… Download pdf

Also relevant:  

Watson, P.H., Hewitt, R.E., Catchpoole, D.R., Grizzle, W.E.  Biobank: What’s in a Name? (The Experts Speak). Biopreserv. Biobank 17, 204 – 208 (2019) 

https://doi.org/10.1089/bio.2019.29053.mjb